AstraZeneca Ends Production of Vaxzevria Amid Falling Global Demand, No Health Risks Cited
9 May 2024AstraZeneca has announced the end of its COVID-19 vaccine Vaxzevria's production, citing decreased global demand and not health concerns. Over 6.5 million lives have been protected by Vaxzevria, with three billion doses distributed worldwide.